Clinical ConvergenceSM: Patient and Provider Perspectives on Care for Chronic Urticaria (CU)
Allergy/ Immunology
Curriculum:
Clinical ConvergenceSM: Patient and Provider Perspectives on Care for Chronic Urticaria (CU)
Clinical ConvergenceSM: Patient and Provider Perspectives on Care for Chronic Urticaria (CU)
Credits:
1.25 AMA PRA Category 1 Credit(s) ™
1.25 AMA PRA Category 1 Credit(s) ™
Launch Date:
May 26, 2016
May 26, 2016
Expiration Date:
The accreditation for this activity has expired.
The accreditation for this activity has expired.
Primary Audience:
Allergists/immunologists, dermatologists, and primary care physicians, nurse practitioners, and physician assistants
Relevant Terms:
Chronic Urticaria
Michael E. Manning, MD
Michael E. Manning, MD
President/Medical Director
Medical Research of Arizona
Allergy, Asthma & Immunology Associates, Ltd.
Scottsdale, Arizona
Bio
Michael E. Manning, MD, is president of Allergy, Asthma & Immunology Associates, Ltd., and medical director of the clinical research division, Medical Research of Arizona.Dr. Manning is a graduate of Baylor University in Waco, Texas, and he received his medical degree from the University of Texas Medical School at Houston. He completed an internship and subsequent residency in internal medicine at St. Joseph’s Hospital and Medical Center in Phoenix, Arizona, and an allergy and immunology fellowship at Scripps Clinic and Research Foundation in La Jolla, California.
Dr. Manning has served as president of the Greater Phoenix Allergy Society, the Arizona State Allergy and Asthma Society, and the Western Society of Allergy, Asthma and Immunology. He is a fellow of the American Academy of Allergy, Asthma and Immunology, and the American College of Allergy, Asthma and Immunology, and he is a member of the American Thoracic Society and the American College of Physicians. Dr. Manning is currently on the Board of Regents of the American College of Allergy, Asthma and Immunology.
| 1. | Formulate an appropriate diagnostic workup for symptomatology suggestive of chronic urticaria (CU) taking into account the potential differential diagnosis | 2. | Screen for and assess quality of life issues in patients with CU |
| 3. | Incorporate into practice evidence-based treatment options and guidelines for managing CU that maximize efficacy while minimizing adverse effects | 4. | Utilize the principles of patient engagement and shared decision-making to implement strategies for effective management of quality of life issues in patients with CU |
| 1. | Formulate an appropriate diagnostic workup for symptomatology suggestive of chronic urticaria (CU) taking into account the potential differential diagnosis |
| 2. | Screen for and assess quality of life issues in patients with CU |
| 3. | Incorporate into practice evidence-based treatment options and guidelines for managing CU that maximize efficacy while minimizing adverse effects |
| 4. | Utilize the principles of patient engagement and shared decision-making to implement strategies for effective management of quality of life issues in patients with CU |
PHYSICIAN CONTINUING MEDICAL EDUCATION
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and RMEI Medical Education, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and RMEI Medical Education, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflicts of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflicts of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
- Michael E. Manning, MD, has affiliations with Genentech (Fees for Non-CME/CE Services Received Directly from a Commercial Interest or Their Agents [e.g., Speakers’ Bureaus]) and Novartis (Research).
RMEI Medical Education, LLC
- Sherri Kramer, MD, has no affiliations with commercial interests to disclose.
- Amy Reeve has no affiliations with commercial interests to disclose.
Postgraduate Institute for Medicine
The following PIM planners and managers, Judi Smelker-Mitchek, RN, BSN, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, and Jan Schultz, MSN, RN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Estimated time to complete: 1.25 hours
Medium: Internet
Medium: Internet
FEE INFORMATION
There is no fee for this educational activity.
COMMERCIAL SUPPORT
This activity is supported by an independent educational grant from Genentech.
HOW TO RECEIVE CREDIT
By reviewing the course content and successfully completing the post-test and evaluation, physicians are entitled to receive up to 1.25 AMA PRA Category 1 Credit(s)™. A statement of credit will be available to print from your user history page. Users must:
- Read the learning objectives and faculty disclosures.
- Participate in the activity.
- Complete the post-test and activity evaluation.
You must score 75% or higher on the post-test to receive credit for this activity. All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.
COURSE VIEWING REQUIREMENTS
| Supported Browsers: Internet Explorer 9.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 Google Chrome 28.0+ for Windows, Mac OS, or Linux Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux Safari 6.0+ for Mac OSX 10.7 and above | Supported Phones & Tablets: Android 4.0.3 and above iPhone/iPad with iOS 6.1 or above. |
© 2007-2024 HealthCourse, Inc. All rights reserved.
